Financial Ratios

NEW HEAVEN CHEMICALS AND INDUSTRIES LTD.

NSE : NABSE : 524484ISIN CODE : INE358P01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE8.000 (0 %)
PREV CLOSE ( ) 8.00
OPEN PRICE ( ) 8.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 700
TODAY'S LOW / HIGH ( )8.00 8.00
52 WK LOW / HIGH ( ) 88
NSE
This Company is not listed in NSE
Select year
ParticularsMar2017Mar2016Mar2015Mar2014Mar2013
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.20-0.27-3.35-0.32-0.79
   CEPS(Rs)-0.16-0.21-3.27-0.32-0.79
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-11.02-10.82-35.58-31.28-30.94
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)
   EBIT Margin(%)
   Pre Tax Margin(%)
   PAT Margin (%)
   Cash Profit Margin (%)
Performance Ratios
   ROA(%)-3.18-4.28-39.98-3.14-6.90
   ROE(%)0.000.000.000.000.00
   ROCE(%)-3.21-4.30-40.18-3.14-7.35
   Asset Turnover(x)0.000.000.000.000.00
   Sales/Fixed Asset(x)0.000.000.000.000.00
   Working Capital/Sales(x)0.000.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)
   Receivable days
   Inventory Days
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.00-37.930.00-73.150.00
   Price/Book(x)0.00-0.740.00-0.760.00
   Yield(%)0.000.00
   EV/Net Sales(x)
   EV/Core EBITDA(x)-174.31-119.46-15.89-201.41-65.04
   EV/EBIT(x)-136.08-92.76-15.50-201.41-65.04
   EV/CE(x)4.323.978.126.314.95
   M Cap / Sales
Growth Ratio
   Net Sales Growth(%)
   Core EBITDA Growth(%)25.6493.57-906.5258.82-385.42
   EBIT Growth(%)26.0491.92-931.7358.82-385.42
   PAT Growth(%)26.2191.87-930.6258.79-385.72
   EPS Growth(%)26.2091.87-930.6258.79-385.72
Financial Stability Ratios
   Total Debt/Equity(x)-1.56-1.58-1.18-1.33-1.33
   Current Ratio(x)0.720.550.815.393.29
   Quick Ratio(x)0.720.550.815.393.29
   Interest Cover(x)-269.90-164.42-4677.87-778.01-1639.23
   Total Debt/Mcap(x)2.131.75

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.